Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease

References

• Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. (2000). Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287:860–864.
   PubMed Web of Science ®Google Scholar
• Bach DS, Radeva JI, Birnbaum HG, Fournier AA, Tuttle EG. (2007). Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind? J Heart Valve Dis 16:362–369.
   PubMed Web of Science ®Google Scholar
• Balmer C, Beghetti M, Fasnacht M, Friedli B, Arbenz U. (2004). Balloon aortic valvoplasty in paediatric patients: progressive aortic regurgitation is common. Heart 90:77–81.
   PubMed Web of Science ®Google Scholar
• Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G. (2010). Insights into the use of biomarkers in calcific aortic valve disease. J Heart Valve Dis 19:441–452.
   PubMed Web of Science ®Google Scholar
• Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H. (2004). Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109:2302–2308.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Cho HJ, Kim HS. (2009). Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 11:206–213.
   PubMed Web of Science ®Google Scholar
• Cowell SJ, Newby DE, Boon NA, Elder AT. (2004). Calcific aortic stenosis: same old story? Age Ageing 33:538–544.
   PubMed Web of Science ®Google Scholar
• Davies SW, Gershlick AH, Balcon R. (1991). Progression of valvar aortic stenosis: a long-term retrospective study. Eur Heart J 12:10–14.
   PubMed Web of Science ®Google Scholar
• Freeman RV, Otto CM. (2005). Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111:3316–3326.
   PubMed Web of Science ®Google Scholar
• Goldbarg SH, Elmariah S, Miller MA, Fuster V. (2007). Insights into degenerative aortic valve disease. J Am Coll Cardiol 50:1205–1213.
   PubMed Web of Science ®Google Scholar
• Jono S, Peinado C, Giachelli CM. (2000). Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275:20197–20203.
   PubMed Web of Science ®Google Scholar
• Koos R, Kühl HP, Mühlenbruch G, Wildberger JE, Günther RW, Mahnken AH. (2006). Prevalence and clinical importance of aortic valve calcification detected incidentally on CT scans: comparison with echocardiography. Radiology 241:76–82.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. (2010). Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607.
   PubMed Web of Science ®Google Scholar
• Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D. (2006). Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J 27:802–807.
   PubMed Web of Science ®Google Scholar
• Mohler ER 3rd, Adam LP, McClelland P, Graham L, Hathaway DR. (1997). Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 17:547–552.
   PubMed Web of Science ®Google Scholar
• Ngo DT, Heresztyn T, Mishra K, Marwick TH, Horowitz JD. (2007). Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA). Nitric Oxide 16:197–201.
   PubMed Web of Science ®Google Scholar
• O’Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. (1995). Osteopontin is expressed in human aortic valvular lesions. Circulation 92:2163–2168.
   PubMed Web of Science ®Google Scholar
• O’Brien KD. (2006). Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26:1721–1728.
   PubMed Web of Science ®Google Scholar
• Perin MA, Brito FS Jr, Almeida BO, Pereira MA, Abizaid A, Tarasoutchi F, Grube E. (2009). Percutaneous aortic valve replacement for the treatment of aortic stenosis: early experience in Brazil. Arq Bras Cardiol 93:299–306.
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. (2003). Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107:2181–2184.
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, Webb JG, Babaliaros VC, Bowers BS, Fearon WF, Herrmann HC, Kapadia S, Kodali SK, Makkar RR, Pichard AD, Cohen DJ; for the Placement of Aortic Transcatheter Valves (PARTNER) Investigators. (2011). Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis. Circulation 124:1964–1972.
   PubMed Web of Science ®Google Scholar
• Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H. (2000). Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 343:611–617.
   PubMed Web of Science ®Google Scholar
• Shen M, Marie P, Farge D, Carpentier S, De Pollak C, Hott M, Chen L, Martinet B, Carpentier A. (1997). Osteopontin is associated with bioprosthetic heart valve calcification in humans. C R Acad Sci III, Sci Vie 320:49–57.
   PubMed Web of Science ®Google Scholar
• Shetty R, Pepin A, Charest A, Perron J, Doyle D, Voisine P, Dagenais F, Pibarot P, Mathieu P. (2006). Expression of bone-regulatory proteins in human valve allografts. Heart 92:1303–1308.
   PubMed Web of Science ®Google Scholar
• Siddiqui RF, Abraham JR, Butany J. (2009). Bioprosthetic heart valves: modes of failure. Histopathology 55:135–144.
   PubMed Web of Science ®Google Scholar
• Soejima H, Irie A, Fukunaga T, Oe Y, Kojima S, Kaikita K, Kawano H, Sugiyama S, Yoshimura M, Kishikawa H, Nishimura Y, Ogawa H. (2007). Osteopontin expression of circulating T cells and plasma osteopontin levels are increased in relation to severity of heart failure. Circ J 71:1879–1884.
   PubMed Web of Science ®Google Scholar
• Soejima H, Irie A, Fukunaga T, Sugamura K, Kojima S, Sakamoto T, Yoshimura M, Kishikawa H, Nishimura Y, Ogawa H. (2006). Elevated plasma osteopontin levels were associated with osteopontin expression of CD4+ T cells in patients with unstable angina. Circ J 70:851–856.
   PubMed Web of Science ®Google Scholar
• Speer MY, Giachelli CM. (2004). Regulation of cardiovascular calcification. Cardiovasc Pathol 13:63–70.
   PubMed Web of Science ®Google Scholar
• Wang A, Harrison JK, Bashore TM. (1997). Balloon aortic valvuloplasty. Prog Cardiovasc Dis 40:27–36.
   PubMed Web of Science ®Google Scholar
• Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C. (2005). Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 26:1023–1030.
   PubMed Web of Science ®Google Scholar
• Yu PJ, Skolnick A, Ferrari G, Heretis K, Mignatti P, Pintucci G, Rosenzweig B, Diaz-Cartelle J, Kronzon I, Perk G, Pass HI, Galloway AC, Grossi EA, Grau JB. (2009). Correlation between plasma osteopontin levels and aortic valve calcification: potential insights into the pathogenesis of aortic valve calcification and stenosis. J Thorac Cardiovasc Surg 138:196–199.
   PubMed Web of Science ®Google Scholar